These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 12121564

  • 1. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B, Saraswat A, Kaur I.
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [Abstract] [Full Text] [Related]

  • 2. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
    Ng LC, Lee YY, Lee CK, Wong SM.
    Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
    [Abstract] [Full Text] [Related]

  • 3. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
    Boffa MJ, Chalmers RJ, Haboubi NY, Shomaf M, Mitchell DM.
    Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
    [Abstract] [Full Text] [Related]

  • 4. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
    van Dooren-Greebe RJ, Kuijpers AL, Termorshuizen F, van de Kerkhof PC.
    Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
    [Abstract] [Full Text] [Related]

  • 5. Short term methotrexate therapy in psoriasis.
    Kumar B, Handa S, Kaur I.
    Indian J Med Res; 1994 Dec; 100():277-80. PubMed ID: 7829167
    [Abstract] [Full Text] [Related]

  • 6. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA, Snoek J, de Jong EM, van de Kerkhof PC, van Oijen MG, van Krieken JH, Drenth JP.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):805-11. PubMed ID: 16918884
    [Abstract] [Full Text] [Related]

  • 7. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A, Poulsen H.
    Acta Pathol Microbiol Scand A; 1976 May 01; 84(3):262-70. PubMed ID: 1274591
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
    Themido R, Loureiro M, Pecegueiro M, Brandão M, Campos MC.
    Acta Derm Venereol; 1992 Sep 01; 72(5):361-4. PubMed ID: 1361285
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
    Cabello Zurita C, Grau Pérez M, Hernández Fernández CP, González Quesada A, Valerón Almazán P, Vilar Alejo J, Carretero Hernández G.
    J Dermatolog Treat; 2017 Aug 01; 28(5):401-405. PubMed ID: 28001499
    [Abstract] [Full Text] [Related]

  • 10. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar 01; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 11. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
    de Jong EM, Mørk NJ, Seijger MM, De La Brassine M, Lauharanta J, Jansen CT, Guilhou JJ, Guillot B, Ostrojic A, Souteyrand P, Vaillant L, Barnes L, Rogers S, Klaber MR, Van De Kerkhof PC.
    Br J Dermatol; 2003 Feb 01; 148(2):318-25. PubMed ID: 12588386
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC, Cássia FF, Lamy F, Chagas VL, Ramos-e-Silva M.
    J Eur Acad Dermatol Venereol; 2008 Jan 01; 22(1):25-9. PubMed ID: 18181969
    [Abstract] [Full Text] [Related]

  • 13. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS, Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP).
    JAMA Dermatol; 2017 Nov 01; 153(11):1147-1157. PubMed ID: 28903160
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate in childhood psoriasis.
    Kumar B, Dhar S, Handa S, Kaur I.
    Pediatr Dermatol; 1994 Sep 01; 11(3):271-3. PubMed ID: 7971565
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S, Krishna V, Kanwar AJ.
    Clin Exp Dermatol; 2012 Oct 01; 37(7):729-34. PubMed ID: 22830389
    [Abstract] [Full Text] [Related]

  • 16. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J, Simková M, Vanecková J, Hroch M, Chládkova J, Martínková J, Vávrová J, Beránek M.
    Eur J Clin Pharmacol; 2008 Apr 01; 64(4):347-55. PubMed ID: 18163165
    [Abstract] [Full Text] [Related]

  • 17. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S, Mahajan R.
    Clin Exp Dermatol; 2013 Aug 01; 38(6):573-88. PubMed ID: 23837932
    [Abstract] [Full Text] [Related]

  • 18. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A, Tan E, Ilchyshyn A, Berth-Jones J.
    Br J Dermatol; 2006 Jun 01; 154(6):1169-74. PubMed ID: 16704650
    [Abstract] [Full Text] [Related]

  • 19. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M, Rafiei B, Moosavi ZB, Sina N.
    Int J Dermatol; 2011 Oct 01; 50(10):1291-3. PubMed ID: 21950300
    [Abstract] [Full Text] [Related]

  • 20. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
    Rademaker M, Gupta M, Andrews M, Armour K, Baker C, Foley P, Gebauer K, George J, Rubel D, Sullivan J.
    Australas J Dermatol; 2017 Aug 01; 58(3):166-170. PubMed ID: 27402434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.